Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

593
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
593
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

500
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
500
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

300
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
300
Drug Product Stability01:16

Drug Product Stability

373
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
373

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Exploration of Heart Rate Response and Blood Tetrahydrocannabinol (THC) Levels to Commercially Available Cannabis Edibles by Dose.

Research square·2026
Same author

Cumulative experiences of racism and mental health outcomes in Colorado minority adolescents.

Frontiers in public health·2026
Same author

Making highways and workplaces safer: An interpretable machine learning approach to predicting recent cannabis use and impairment.

Journal of safety research·2026
Same author

Advancing translational science through biostatistics, epidemiology, and research design consultations: A multi-perspective evaluation of the Georgia CTSA BERD program.

Journal of clinical and translational science·2026
Same author

Health Behavior Changes in a Lifestyle Medicine Program: A Convergent Mixed Methods Study.

Behavior modification·2026
Same author

Effectiveness of the Botvin High School LifeSkills Training Intervention on Adolescent Substance Use: A Cluster Randomized Trial.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2026

Related Experiment Video

Updated: May 5, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
09:24

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Published on: August 22, 2017

8.3K

Commercial Cannabis Product Testing: Fidelity to Labels and Regulations.

Sarah Limbacher1, Suneeta Godbole2, Julia Wrobel3

  • 1Colorado School of Public Health, Injury and Violence Prevention Center.

Medrxiv : the Preprint Server for Health Sciences
|March 31, 2025
PubMed
Summary

Cannabis product labels in Colorado often show higher Tetrahydrocannabinol (THC) concentrations than actual products, especially for flower and edibles. Accurate THC labeling is crucial for consumer trust and evolving cannabis regulations.

Keywords:
CannabisFDAProduct testingcommercial cannabisstate policystate regulations

More Related Videos

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
07:29

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis

Published on: November 11, 2022

1.9K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.2K

Related Experiment Videos

Last Updated: May 5, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
09:24

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Published on: August 22, 2017

8.3K
HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
07:29

HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis

Published on: November 11, 2022

1.9K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.2K

Area of Science:

  • Cannabis Science
  • Analytical Chemistry
  • Regulatory Science

Background:

  • Colorado regulations mandate Tetrahydrocannabinol (THC) concentration labeling on recreational and medical cannabis.
  • Labeled THC concentrations have a legally allowable variance of +/-15% from the actual content.
  • Previous studies indicate discrepancies between labeled and actual THC levels, influencing consumer purchasing decisions.

Purpose of the Study:

  • To evaluate the accuracy of THC concentrations on cannabis product labels in Colorado.
  • To compare THC label accuracy across different product types (flower, concentrate, edible).
  • To assess label accuracy relative to the legally permissible variation.

Main Methods:

  • Analysis of 74 cannabis samples (flower, concentrate, edible) from licensed Colorado dispensaries.
  • Independent laboratory testing of collected samples to determine actual THC concentration.
  • Comparison of labeled THC values against independently measured values.

Main Results:

  • Labeled THC values were significantly higher than observed values for flower and edible products (p < 0.001).
  • Flower products showed significantly lower labeled THC compared to the 15% allowable range (p = 0.04).
  • No significant difference was found between labeled and observed THC for concentrate products (p = 0.85).

Conclusions:

  • Discrepancies exist between labeled and actual THC content in Colorado cannabis products, particularly for flower and edibles.
  • Current labeling practices may not accurately reflect product content within legal tolerances.
  • There is a pressing need for enhanced standards and regulations to ensure accurate THC reporting on cannabis labels.